In particular, we observed a strong trend toward reduction in the severity of the disease between the LXA 4 -prophylactic-treated mice and the vehicle-treated mice ( Figure 1D ; Tables S1 and S2 ).
← all excerpts
Pro-resolving lipid mediator lipoxin A<sub>4</sub> attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome.
2
—
—
The sentences
Overall, these results indicated that the production of specific cytokines that characterize the main pro-inflammatory T cell subsets from control or patients with MS was significantly reduced or showed a trend toward significance upon pre-treatment with LXA 4 , indicating that LXA 4 regulates human T cell responses as well as their transmigration capacity.